Editorial: Bridging translational gaps in cardiovascular disease through large animal research

Read full text Summarise with VIRAT
Authors: Gerard Amorós-Figueras, André M. Leite-Moreira, Alessio Alogna, DeLisa Fairweather
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Cardiovascular diseases (CVDs) remain the leading cause of global mortality, accounting for nearly 16 20 million deaths annually. As we enter an era defined by rapid advancements in in silico modeling, 17 organ-on-a-chip technologies, and complex organoids, a critical question arises: Is the use of large 18 animal models still relevant in modern cardiovascular research? While alternative models o er high-19 throughput potential and address specific ethical concerns, they often struggle to replicate the 20 integrated systemic physiology electrophysiology and complex hemodynamics of the human heart. immunosuppression. This study is particularly significant for identifying the contribution of 66 immunosuppressive mediators and paracrine e ects that allow for stem cell retention and 67 endothelial recruitment, paving the way for o -the-shelf allogeneic stem cell therapies. 68Finally, the utility of many of these large animal models depends on the accuracy of our diagnostic 69 tools. In this research topic, Billig et al.( 6) have proposed a method to perform standardized 70 subxiphoid echocardiography (SE) in swine. The authors have described in detail the specific 71 surgical approach and imaging protocol and also have provided reference values for parameters 72 such as LV stroke volume, ejection fraction, and global longitudinal strain. Standardizing these 73 measurements is essential for ensuring reproducibility across di erent research centers and 74 improving the quality of translational cardiovascular data. 75In conclusion, the six articles presented in this Research Topic reinforce that large animal models 76 remain indispensable to translational medicine. Rather than being replaced by alternative methods, 77 new technologies allow these models to be improved and more closely mimic clinical reality, 78 thereby increasing their translational relevance. By bridging the gap between benchtop innovation 79 and the bedside, these advancements ensure that large animal research remains more essential 80 and rigorous than ever.In summary, this Research Topic highlights the indispensable role of large 81 animals in translating cardiovascular discoveries from the laboratory to the clinic. By refining our 82 models to be more pathomimetic and less stressful for the animals, we improve both the ethical 83 standing and the predictive power of our science. Whether through the development of "o -the-84 shelf" stem cell therapies, the rigorous testing of TAVI devices, or the standardization of imaging 85 protocols, these studies contribute to a more robust framework for cardiovascular innovation. 86We would like to thank all the authors for their innovative submissions and the reviewers for their 87 dedication to ensuring the quality of this Research Topic. We hope this collection serves as a 88 valuable resource for scientists and clinicians working to bridge the gap in cardiovascular therapy. 89 90

Fields of Study & Subjects

Animal testing and alternatives Cardiac electrophysiology and arrhythmias Cardiovascular Function and Risk Factors

Publication details

Journal / source
Frontiers in Cardiovascular Medicine
Volume
13
Pages
1824781–1824781
Publication date
23 March 2026
Language
EN